Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.01 (+0.97%)
Close on Nov 17, 2026Market cap $13.95MP/E –Yield –
Marker Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Marker Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.76M. For fiscal 2025 it was -$12.01M. The highest annual figure on record is -$694.58K in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.01M | – |
| FY2024 | Dec 31, 2024 | -$10.91M | – |
| FY2023 | Dec 31, 2023 | -$16.44M | – |
| FY2022 | Dec 31, 2022 | -$26.97M | – |
| FY2021 | Dec 31, 2021 | -$27.28M | – |
| FY2020 | Dec 31, 2020 | -$20.03M | – |
| FY2019 | Dec 31, 2019 | -$18.28M | – |
| FY2018 | Dec 31, 2018 | -$14.48M | – |
| FY2017 | Dec 31, 2017 | -$8.44M | – |
| FY2016 | Dec 31, 2016 | -$6.51M | – |
| FY2015 | Dec 31, 2015 | -$4.34M | – |
| FY2014 | Dec 31, 2014 | -$2.19M | – |
| FY2013 | Dec 31, 2013 | -$694.58K | – |
| FY2012 | Dec 31, 2012 | -$1.59M | – |
| FY2011 | Dec 31, 2011 | -$1.31M | – |
| FY2010 | Dec 31, 2010 | -$925.04K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.40M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.90M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.74M | -328.5% |
| Q2 FY2025 | Jun 30, 2025 | -$1.88M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.70M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.57M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.13M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.89M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$794.71K | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.23M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.86M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.54M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.79M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.50M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.13M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.30M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.66M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.88M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.40M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.35M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.48M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.03M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.01M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.92M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.75M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.97M | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.95M | – |
See a number that looks wrong?